IGF-I, IGF-I-binding proteins and GH-binding protein in malnurished elderly patients with inflammation receiving refeeding therapy

European Journal of Endocrinology

Volumn 146, Issue 5, 2002, Pages 657-665

  Raynaud Simon, A ^a   Perin, L ^a   Meaume, S ^a   Lesourd, B ^a   Moulias, R ^a   Postel Vinay, M C ^a   Le Bouc, Y ^a  

^a HÔPITAL CHARLES FOIX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE BINDING PROTEIN; SERUM ALBUMIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AGED; ARTICLE; BODY WEIGHT; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOOD INTAKE; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; MALE; MALNUTRITION; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; REFEEDING; TREATMENT OUTCOME;

EID: 0036099104     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460657     Document Type: Article

References (49)

1. Protein-calorie undernutrition in the nursing home
2. Impact of nutrition on morbidity and mortality in a select population of geriatric rehabilitation patients
3. Protein-energy malnutrition in elderly medical patients
4. Dietary supplementation in elderly patients with fractured neck of the femur
5. The risk of life-threatening complications in a select population of geriatric patients: The impact of nutritional status
6. The acute phase response
7. Nutritional aspects of leukocyte cytokines: Critical review
8. Weight loss associated with an endotoxin-induced mediator from peritoneal macrophage: The role of cachectin (tumor necrosis factor)
9. The nutritional status and clinical course of acute admissions to a geriatric unit
10. Body mass index, weight change, and risk of mobility disability in middle-aged and older women. The epidemiologic follow-up study of NHANES I
11. The importance of dietary protein in healing of pressure ulcers
12. Nutritional regulation of the insulin-like growth factors
13. Metabolic effects of IGFs
14. Normal growth and development in the absence of hepatic insulin-like growth factor I
15. Insulin-like growth factors and their binding proteins: Biological actions
16. In vivo proteolysis of serum insulin-like growth-factor (IGF) binding protein-3 results in increased availability of IGF to target cells
17. Acute and prolonged critical illness as different neuroendocrine paradigms
18. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: Effect of short- and long-term recuperation
19. Growth hormone receptors in rat liver membranes: Effect of fasting and refeeding and correlation with plasma somatomedin activity
20. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness
21. Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery
22. The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery
23. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP)1, 2 and 3 after elective abdominal surgery
24. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor protease
25. The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness
26. Health-measures correlates in a French elderly community population: The PAQUID study
27. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: Repercussions on reproduction, ante- and perinatal mortality and postnatal growth
28. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: Relationships with growth hormone and IGFs and physiological significance
29. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies
30. Evidence that limited proteolysis of insulin-like growth factor binding protein 3 (IGFBP-3) occurs in the normal state outside the bloodstream
31. Evaluation of the growth hormone-binding proteins in human plasma using high pressure liquid chromatography gel filtration
32. Ligand: A versatile computerised approach for characterization of ligand systems
33. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients
34. Whole body protein kinetics in severely septic patients
35. Accelerated nitrogen loss after traumatic injury is not attenuated by achievement of energy balance
36. Limitations of nutrient intake. The effect of stressors: Trauma, sepsis and multiorgan failure
37. The role of IGFs in catabolism
38. Insulin and insulin-like growth factor I enhances human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms
39. Recombinant human insulin-like growth factor I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect
40. Dietary components that regulate serum somatomedin-C concentrations in humans
41. Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis
42. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity
43. Nutritional status and growth hormone-binding protein
44. Inhibition by interleukin-1β and tumor necrosis factor-α of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture
45. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I
46. Selective involvement of interleukin-6 in the transcriptional activation of the suppressor of cytokine signaling-3 in the brain during systemic immune challenges
47. Role of suppressor of signaling-3 in mediating the inhibitory effects of interleukin-1β on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells
48. Protease-induced alteration of insulin-like growth factor binding protein-3 as detected by radioimmunoassay. Agreement with ligand blotting data
49. Insulin-like growth factor binding protein (IGFBP) proteolysis: Occurrence, identification, role and regulation